Terms: = Cervical cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
29 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. [Treatment and prognosis analysis of 488 patients with FIGO 2018 stage Ⅲc squamous cervical cancer].
Feng T; Shou HF; Yuan SH; Tang HR; Lyu XJ; Yin ZM; Lou HM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):359-367. PubMed ID: 37217343
[No Abstract] [Full Text] [Related]
3. The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
Cho WK; Kim HS; Park W; Kim YS; Kang J; Kim YB; Kim YS; Kim YJ; Kim KR; Kim JH; Kwon SY; Choi JH; Yoon M; Kim NI
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):154-163. PubMed ID: 36935025
[TBL] [Abstract] [Full Text] [Related]
4. Advanced Ann Arbor stage and age over 60 years as prognostic predictors in patients with primary cervical lymphoma: a retrospective cohort study and systematic review.
Gao L; Chen X; Zhao J; Xu A; Liu M; Yu H; Kong S; Li S
BMC Cancer; 2023 Jan; 23(1):95. PubMed ID: 36707772
[TBL] [Abstract] [Full Text] [Related]
5. cancer incidence and mortality in Quito: information to monitor cancer control policies.
Cueva P; Tarupi W; Caballero H
Colomb Med (Cali); 2022; 53(1):e2024929. PubMed ID: 36415599
[TBL] [Abstract] [Full Text] [Related]
6. Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer.
Sun W; Hang D; Han S; Fu S; Ma H; Dong X; Xu Y; Li N; Hu Z
Gene; 2022 Nov; 844():146824. PubMed ID: 35995117
[TBL] [Abstract] [Full Text] [Related]
7. prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in cervical cancer.
Lang X; Huang C; Cui H
J Immunol Res; 2022; 2022():4954457. PubMed ID: 35942212
[TBL] [Abstract] [Full Text] [Related]
8. Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
Shiri Aghbash P; Shirvaliloo M; Khalo Abass Kasho A; Alinezhad F; Nauwynck H; Bannazadeh Baghi H
Int Immunopharmacol; 2022 Jul; 108():108896. PubMed ID: 35640377
[TBL] [Abstract] [Full Text] [Related]
9. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
10. Risk of Gynecologic cancer as Second versus First Primary cancer in Japan.
Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
[TBL] [Abstract] [Full Text] [Related]
11. Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study.
Du YY; Luo DH; Sun XS; Tang LQ; Mai HQ; Chen QY; Zhong JH; Mai DM; Zhang WR; Chen WH; Mo HY
Cancer Med; 2019 Nov; 8(16):6841-6852. PubMed ID: 31513364
[TBL] [Abstract] [Full Text] [Related]
12. Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.
Ino Y; Akimoto T; Takasawa A; Takasawa K; Aoyama T; Ueda A; Ota M; Magara K; Tagami Y; Murata M; Hasegawa T; Saito T; Sawada N; Osanai M
Histol Histopathol; 2020 Apr; 35(4):351-359. PubMed ID: 31483053
[TBL] [Abstract] [Full Text] [Related]
13. RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/β-catenin signaling.
Mei Y; Liu YB; Cao S; Tian ZW; Zhou HH
Cell Death Dis; 2018 Sep; 9(10):942. PubMed ID: 30237512
[TBL] [Abstract] [Full Text] [Related]
14. HPV infection and p16
Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
[TBL] [Abstract] [Full Text] [Related]
15. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy.
Bohr Mordhorst L; Ahlin C; Sorbe B
Oncotarget; 2016 Sep; 7(39):63042-63053. PubMed ID: 27577083
[TBL] [Abstract] [Full Text] [Related]
17. Epithelial-mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy.
Rojas-Puentes L; Cardona AF; Carranza H; Vargas C; Jaramillo LF; Zea D; Cetina L; Wills B; Ruiz-Garcia E; Arrieta O
Cancer Med; 2016 Aug; 5(8):1989-99. PubMed ID: 27230280
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China.
Qian Q; Yang J; Cao D; You Y; Chen J; Shen K
J Gynecol Oncol; 2014 Oct; 25(4):293-300. PubMed ID: 25142622
[TBL] [Abstract] [Full Text] [Related]
19. Clinical significance of the stem cell gene Oct-4 in cervical cancer.
Yang Y; Wang Y; Yin C; Li X
Tumour Biol; 2014 Jun; 35(6):5339-45. PubMed ID: 24532469
[TBL] [Abstract] [Full Text] [Related]
20. Dissecting the phenotypes of Plk1 inhibition in cancer cells using novel kinase inhibitory chemical CBB2001.
Lan R; Lin G; Yin F; Xu J; Zhang X; Wang J; Wang Y; Gong J; Ding YH; Yang Z; Lu F; Zhang H
Lab Invest; 2012 Oct; 92(10):1503-14. PubMed ID: 22890557
[TBL] [Abstract] [Full Text] [Related]
[Next]
